Pediatric clinical trials surge as funding and regulatory incentives reshape drug development
A new wave of investment and regulatory support is driving pediatric clinical trials toward a projected USD 35.64 billion market by 2035, with Asia Pacific leading growth and oncology trials gaining momentum.